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Abstract
Background: In recent years, intra arterial chemotherapy has become an important
component in head and neck cancer treatment. However, therapy success can vary
significantly and consistent treatment guidelines are missing. The purpose of this
study was to create a computer simulation of the chemical agent injection in the
head and neck arteries to investigate the distribution and concentration of the
chemical.
Methods: Realistic three dimensional patient specific geometry was created from
image scan data. Pulsatile blood flow, turbulence, the chemical agent injection via a
catheter, and the mixture between blood and the chemical were then simulated
through the arterial network by computational fluid dynamics software.
Results: The results show a consistent chemical distribution throughout all the
arteries and this is ineffective. In addition, due to high wall shear stress and
turbulence at the inner bifurcation wall, serious complications during the treatment
could occur, for instance haemolysis or thrombosis.
Conclusions: The modelled catheter position is insufficient to provide a high
chemical agent concentration in the desired tumour feeding artery, which is vital for
therapy success.
Keywords: patient specific model, blood flow dynamics, non-Newtonian, chemother-
apy, multiphase model
1 Background
In head and neck cancer treatment and particularly in oral cancer treatment, surgery
or radiotherapy alone or radiotherapy in combination with chemotherapy is generally
administered. All modalities can lead to significant problems with swallowing and
speech with consequent reduction in life quality. The general aim in cancer treatment
is to approach maximum tumour control with minimum related side effects. In recent
years, chemotherapy has become more relevant and is now an important treatment
component in combined modality approaches, several studies in this subject are sum-
marized in [[1], p. 127]. Studies, using concurrent chemoradiation in comparison with
radiation alone, are commonly randomized trials, which vary in radiation dose, fractio-
nation schedule, and administered chemotherapy. The dosage scheme, which is usually
given in mass per body surface area (mg/m2), as well as the administration method of
the chemical is vital for the prognosis.
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Using intra-arterial infusion improved the success of treatment. This is because of
the arteries that supply specific tissue, detailed in [2,3]. This technique allows the sup-
ply of much higher chemical agent concentration directly to the tumour than intra-
venous infusion. The latter, distributes the chemical agent throughout the whole body
and causes increased side effects. Because of the patient specific artery geometry and
resultant haemodynamics, there is no method that always leads to success, and this is
discussed in [4]. The knowledge about the chemical agent concentration in blood and
the technique by which the tumours were infused is vital for therapy success [5]. The
aim is to supply a high application rate of chemical in a specified target region inside
the arterial network.
Advances in computational methods and three-dimensional imaging techniques allow
improved understanding of haemodynamic flow in the cardiovascular network. Com-
putational fluid dynamics (CFD) solves differential equations of fluid flows numerically
and is an excellent technique for analysing and displaying blood flow in the head and
neck arterial network. In contrast to previous studies [6-9], using two or three-dimen-
sional ideal geometry, this project deals with real geometry obtained from image-scan
segmentation of a patient [10-14].
Simulation of patient specific two-component flow, using various injection positions
and parameters, for instance the mass flow rate of the chemical agent, should deepen
the knowledge of chemical agent distribution in the artery network, which is the aim
of this study. If an accurate computer simulation is achievable in a sufficiently short
time, patient specific computation would provide the basis of comparing the effect of
several treatment methods and parameters prior to therapy. A two-component transi-
ent CFD model can assist medical scientists to select the most appropriate treatment
strategy.
2 Methods
Considering the pulsatile character of blood flow, a transient CFD model is required.
The model is reduced to the interesting region of the common carotid artery (CCA)
bifurcation, the lingual artery (LA), facial artery (FA) and superior thyroid artery (STA)
branch, including two-component flow. In particular the CFD model comprises the
two liquids blood (continuous component or primary phase) and the chemical agent
cisplatin (dispersed component or secondary phase). Cisplatin is injected via a catheter
into the arterial blood flow. Due to this, the catheter has to be considered as thin pipe
inside the CCA, because the catheter walls cause wall friction and influence the hae-
modynamic flow pattern.
A patient specific model was created with the image segmentation software Scanip™
[15] from CT-scans, presented in Figure 1. The catheter is an ideal pipe and in clinical
practice has an inner diameter of 0.625 mm, an outer diameter of 0.924 mm and the
common dose rate is approximately 50 ml/20 s. Four different injection positions are
common:
• Short before the common carotid bifurcation.
• Internal carotid artery at the height of the superior thyroid branch.
• Lingual shunt.
• Inside the lingual artery.
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It was decided to compute the first injection position, because the catheter can be
modelled as straight ideal pipe, shown in Figure 1(a). Small pipe geometry creation
using few voxels is complicated in Scanip™. Hence, it is impossible to model the
catheter entirely including the inner wall in such small dimensions. A catheter outer
wall diameter of approximately 1.2 mm (this is 30% larger than the real catheter) and
tolerable wall smoothness was achieved with the CAD primitive generation tools in
Scanip™. An additional volume at the top end of the catheter was created to obtain a
catheter-blood interface in the following mesh import in Gambit™ [16]. Using the
split face tool in Gambit™, this interface was divided by a circle of 0.6 mm diameter
and an ideal circular face for the catheter outflow boundary condition was obtained.
This face is slightly smaller than the real catheter inner diameter. Since the catheter
inner wall is not considered in the model, it was decided to neglect the cisplatin flow
inside the catheter entirely and the catheter volume remains unmeshed. Otherwise
recirculation would occur inside the catheter near the catheter-blood interface. Addi-
tionally the steady ideal pipe flow of cisplatin inside the catheter is entirely solvable
with analytical equations.
The mesh consists of hexahedron elements in the vessel core and tetrahedron ele-
ments adjacent to walls. A mesh independence test was done in a previous steady
simulation on the highest blood flow rate of CCA using wall y+ and pressure gradient
adaption [17]. Due to just slightly monitor data changes after the mesh adaption, the
initial mesh of counting 224,115 cells was taken.
A prior one-phase steady cause and effect study was carried out with various Rey-
nolds numbers and viscous models for blood [17]. In this previous study it was discov-
ered that a non-Newtonian material model was compulsory for blood. Comparing the
velocity magnitude on diametrical line probes at several outlets, significant lower velo-
city values were observed for the non-Newtonian models in small arteries, shown in
Figure 2. In particular, a maximum offset of 20% was computed at the FA outlet
between the Newtonian and the power-law non-Newtonian model due to the very
small FA diameter, approximately 2.9 mm. Moreover, the shear stress transport (SST)
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Figure 1 Two-component CFD model considering the cisplatin injection through a catheter, right
before the CCA bifurcation in Figure (a). Figure (b) shows the right arterial network and skull source
volume model as result of the CT image segmentation in Scanip™. APA-ascending pharyngeal artery; BCA-
brachiocephalic artery; CCA-common carotid artery; ECA-external carotid artery; FA-facial artery; ICA-internal
carotid artery; LA-lingual artery; RSA-right subclavian artery; STA-superior thyroid artery; VA-vertebral artery.
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k-ω turbulence model was found to be appropriate for the whole velocity range and of
superior robustness.
The boundary conditions comprise two mass flow inlets, CCA and catheter, and six
outflow outlets with adjusted flow rate weighting. Several measured data dealing with
CCA blood flow pattern is presented in [18-21]. It is assumed that the additional
catheter inlet in the present model does not change the general flow division in the
CCA bifurcation, due to the modelled catheter position still being inside the CCA.
This is not advisable if the injection position moves downstream, for instance to the
external carotid artery (ECA). Unfortunately it is impossible to consider a time depen-
dent flow rate weighting of the CCA into the ECA and internal carotid artery (ICA) in
the transient solver of Fluent™ as a boundary condition for each outlet. Hence, only a
time averaged flow rate weighting could be used. The time averaged mass loss (ICA +
ECA)/CCA is reported at roughly 5% in [21] and compared with two additional
sources in Table 1. Regarding this 5% to the STA branch, it is assumed that each
branch of the ICA will have the same proportion of approximately 13.5% of the ICA
mass flow. The time averaged mass flow division was calculated for the ECA, STA, LA,
FA and ascending pharyngeal artery (APA) outlet and assumed for the ICA outlet. Fig-
ure 3(a) provides an overview of the time continuous flow rate weighting for all out-
flow conditons.
The most appropriate data for the CCA inlet is given in [21] obtained from older
volunteers and shown with the solid line in Figure 3(b). However, it can be expected
that because of the stress during chemotherapy, the heart rate should be higher than
the reported 65 beats per minute in this source. Additionally, the study was made with
healthy volunteers. Hence, it is not known how a catheter will affect the reported rate
of flow range. These two inlet conditions are converted into a mass flux boundary in
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Figure 2 Velocity profiles over dimensionless vessel diameter with various blood models on a low
Reynolds number, taken from our previous study [17]. Figure (a) shows the RSA with an approximately
diameter of 9.3 mm, Figure (b) shows the velocity profile for the smaller FA with a vessel diameter of 2.9
mm. The non-Newtonian power-law approach results in lower velocity values, due to more viscosity on
low shear rate in the FA in Figure (b). This effect was not observed in the larger RSA in Figure (a).
Table 1 Measurements of the cycle averaged CCA rate of flow division in ml/min and
the relative outflow/inflow mass loss
reference V˙ ICA V˙ ECA V˙ CCA m˙ loss
[21] 245 125 389 4.9%
[32] 248 95 370 7.0%
[33] 255 95 376 6.9%
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the Fluent™ simulation. In particular a transient table for the CCA and a constant
value for cisplatin is used. The volume fraction of the dispersed phase cisplatin was set
to 100% at the cisplatin inlet and 0% at the CCA inlet.
Blood is modelled as a non-Newtonian fluid using the Carreau model (1) with a con-
stant density of r = 1056 kg/m3. The material constants for the haematocrit value of
Ht = 45% and the temparature of T = 310.15 K are given in [[22], pp. 236-237]. The
maximum Reynolds number of the pulsatile blood flow is 856, which indicates laminar
blood flow through the whole cycle.
μ(γ˙ ) = μ∞ + (μ0 − μ∞)[1 + (λtγ˙ )2](n−1)/2,
where μ0 = 0.056 Pas, μ∞ = 0.00345 Pa s,
λt = 3.313 s, n = 0.3568.
(1)
The Newtonian material model was used for cisplatin with properties of water, r =
998.2 kg/m3and μ = 0.001003 Pa s.
The Reynolds number of the steady cisplatin flow inside the catheter is 5331. This is
far above the commonly known threshold for laminar pipe flow Re = 2300. Turbulence
is considered through the SSTk-ω model. At the laminar CCA inlet k and ω is set to 0.
At the turbulent cisplatin inlet on top of the catheter k = 0.359 m2/s2 and ω = 26165 s
-1, determined by using an approach for fully developed turbulent pipe flows (2) dealt
with in [[16], ch. 7.2.2].
k =
3
2
(umag · I)2 with I = 0.16 · Re−
1
8 ,
ω =
k1/2
C1/4μ · lT
with Cμ = 0.09 and lT = 0.07 · dh.
(2)
All walls are rigid and a non-slip condition is prescribed. The mixing model was
used including slip velocity and implicit body force effects. Assuming a bubble size of
0.1 mm for the dispersed phase cisplatin, a hydraulic diameter of dh = 6 mm for the
CCA and a maximum blood velocity of 0.8 m/s, a Stokes number of 0.021 was calcu-
lated using the equations (3), dealt with in [[23], p. 194]. This is much smaller than
one and means that all cisplatin bubbles will closely follow the blood flow. A strong
coupling between blood and cisplatin is supposed.
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Figure 3 Time continuous flow rate weighting off all outlets using the outflow boundary condition
in Figure (a). The asterisked values are the original time averaged data of [21]. The CCA flow rate inlet
condition in Figure (b) is realized as a transient table with 200 equal distant timesteps (0.0047s timestep
size). The cycle time tp is 0.923s, which is equal to 65 heart beats per minute.
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St =
τd
τc
with τd =
ρd · dd2
18μc
and τc =
dh
umag
(3)
After testing one initial cycle using 100 time steps, the transient simulation pro-
ceeded in batch mode using 200 equal distant time steps for one additional cycle. Dou-
ble precision, first order discretization and the pressure based segregated PISO solver
including skewness and neighbour correction of one, were used with a convergence
criteria of 1 · 10-7 for the cisplatin volume fraction residual. All other settings remained
at Fluent™ default values. Data for each 10 th time step was saved. The computing
time required approximately four days, shared by three parallel processors.
3 Results and discussion
Figure 4(a) shows vectors of velocity magnitude in several cross sections coloured by
the turbulent kinetic energy k in the time step with the highest blood volume flow
rate. The catheter inlet vectors are not exactly perpendicularly aligned with the cathe-
ter axis. The cisplatin flow is frontal orientated towards the inner wall of the CCA
bifurcation with a small incline towards the ECA. Creation of the catheter geometry in
CAD software would be useful to obtain a proper plain catheter front surface. This
would be perpendicular, ideally cylindric and the catheter wall would be smooth.
Because of the turbulent Reynolds number inside the catheter, turbulence is introduced
in the blood flow through the cisplatin inlet. And it occurs at both inner walls after the
CCA bifurcation in the ICA and ECA. Sutera and Mehrjardi [24] reported in their
study that the red blood cells deform gradually toward a smooth ellipsoidal shape by
the alternation of the magnitude in the shear stress from 10 Pa to 250 Pa. The region
of fluctuating stresses associated with high turbulent kinetic energy, that indicates high
turbulence and is shown in Figure 4(b), is therefore critical in matters of red blood cell
damage (haemolysis), thrombosis (blood clotting) or even a stroke. Additionally, the
CCA bifurcation is known as region with a high possibility of arteriosclerosis for
ﬀ
(a) (b) (c) (d)
0 0.6 1.2 1.8 2.4 3 · 10−1 m2/s2
0 16 32 48 64 80 Pa
Figure 4 In (a) vectors of velocity magnitude coloured by turbulent kinetic energy k are presented
(range above the colour bar). The catheter on the right is displaced from its origin in the CCA centre.
The mean velocity at CCA inlet is 0.38 ms-1 and at cisplatin inlet 7.66 ms-1. Figure (b) shows the related
contour plot of k. Figure (c) and (d) are plots of wall shear stress in systole and diastole (range below the
colour bar).
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elderly patients. The turbulent cisplatin flow could have an abrasive effect and release
fatty particles.
Furthermore, in consequence of the frontal orientated cisplatin inlet stream towards
the CCA bifurcation wall, the wall shear stress shows a peak (≈ 80 Pa) in this region,
presented in Figure 4(c) and 4(d) for systole and diastole, respectively. This level of
high wall shear stress can potentially cause acute vascular endothelial changes as it was
found in [25] that the acute yield stress is approximately 37.9 Pa.
Due to the toxic properties of cisplatin, this catheter outflow position can cause sev-
eral complications, such as local inflammation and neurological complications, for
instance headache and facial paresis, [3].
The cisplatin distribution during one cardiac cycle can be described in detail by
using Figure 5. In general, the chemical agent cisplatin distributes in all arteries, as to
be expected for this catheter position. This is undesirable, because only a high cisplatin
concentration in a specific region gives maximum tumour control with minimum
related side effects. Prior systole, the path lines indicate recirculation upstream in the
CCA. The cisplatin volume fraction in the ECA is larger than in the ICA. This is
explained by the flow rate weighting conditions of Figure 3(a). With the start of systole
and increasing blood flow, the cisplatin concentration decreases in the larger arteries
ECA and ICA, Figure 5 (c)-(e), and the recirculation region disappears. There is a time
shift in cisplatin volume fraction reduction to note between ECA and LA with FA.
This is shown in Figure 5(d). This shift is retained until the beginning of the diastole
(a) (b) (c) (d)
(e) (f) (g) (h)
0 0.2 0.4 0.6 0.8 1
Figure 5 Path lines with origin cisplatin inlet coloured by volume fraction of cisplatin during one
cardiac cycle. The catheter is hidden. The blood flow condition at the CCA inlet is shown in each picture
on the bottom left.
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in Figure 5(f) when the volume fraction in ECA, LA and FA are approximately equal.
At the end of diastole in Figure 5(g) a similar condition is observed as in Figure 5(a).
This suggests a periodic cisplatin distribution characteristic controlled by the cardiac
cycle. It also shows the importance of considering a pulsatile blood flow boundary con-
dition. If the simulation was steady, a delay in cisplatin concentration at various artery
limits would be invisible in the simulation results.
The mass weighted average cisplatin volume fraction for all 21 saved time steps at all
model outlets is presented in Figure 6. The discussed delay of cisplatin concentration
between ICA and LA with FA is good to observe. In particular, the functions of ICA,
ECA, STA and APA show a qualitatively similar shape contrary to the functions of LA
and FA. Apart from the ICA all arteries have an approximately equal cisplatin concen-
tration range between 0.3 and 0.5. It is not expected that a variation in cisplatin dosage
will change this uniform distribution, rather a catheter position further downstream
could have a positive effect in this matter.
Additionally, the time dependent cisplatin concentration functions, observed for all
outlets, indicate that the time continuous boundary condition at the cisplatin inlet is
not the most efficient technique for applying high chemical agent dosages. It is possi-
ble that an unsteady injection at a particular beneficial time range on higher dosage
rate could enhance the cisplatin concentration and reduce side effects, such as local
inflammation at artery walls, during the remaining period. An advantageous time range
for injection would be between t/tp = 0-0.3 during peak systole. Furthermore, it is pos-
sible that recirculation and the exposure time on high turbulence could be reduced by
time dependent injection during systole. Future simulations are required to provide
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Figure 6 Mass weighted average cisplatin volume fraction at the outlets over one cardiac cycle.
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Figure 7 Cisplatin rate of flow at the outlets. Figure (b) shows the outlets STA, LA, FA and APA of
Figure (a) separately with a finer ordinate resolution.
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evidence for this assumptions. In absolute values, Figure 7 represents the rate of flow
of the chemical. The prescribed flow rate weighting is the reason for the low level of
STA, LA, FA and APA compared with ECA and ICA.
4 Conclusions
The distribution and concentration of the chemical agent cisplatin have been investi-
gated in a realistic three dimensional patient specific geometry of human head and
neck arteries. The used injection position gives an ineffective cisplatin division. This
means that the chemical agent is distributed in all arteries and not in one specific
tumour feeding artery, a fact of great importance. High wall shear stress and turbu-
lence near the CCA bifurcation inner walls can cause serious harm, for instance acute
vascular endothelial changes or haemolysis. It should be expected that an injection
position in the core of the artery further downstream would reduce this high exposure.
The time continuous cisplatin inlet condition seems to be ineffective during diastole,
when upstream recirculation in the CCA mainly occurs. It should be investigated if a
time dependent injection during the advantageous systole would lead to an equal cycle
averaged cisplatin concentration with reduced side effects caused by the catheter
inflow.
In blood flow CFD simulation using multiphase models, neither mass flow nor velo-
city outlets are practicable, due to required outlet data for each phase. This data is
unknown a priori for the secondary phase cisplatin and is the aim of this simulation.
An assumed flow rate weighting was used in this model based on measured data for
the two main outlets ICA and ECA. It is assumed that the general blood flow division
remains unchanged in comparison with measured data of healthy volunteers in the
normal state. An injection position further downstream in a side branch of the ECA
would probably change the blood flow division. An alternative proper methodology
would be to use the pressure inlet and outlet boundary conditions, that require only
the volume fraction of the secondary phase at the inlets, and adjust the pressure to a
correct level. However, time dependent pressure functions for each model boundary
were not available and are difficult to assess for small arteries, such as the LA and FA.
The implementation of an arterial one dimensional model seams to be the superior
way for future CFD simulations dealt with in [26-31].
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